LUMBOSACRAL RADICULOPATHY

This adverse event was reported 161 times

LUMBOSACRAL RADICULOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE 1 0.0156
1 ELRANATAMAB-BCMM 3 0.0026
2 BARIUM SULFATE 1 0.0023
3 EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) 1 0.0021
4 SULFACETAMIDE SODIUM 1 0.0020
5 ALENDRONATE SODIUM AND CHOLECALCIFEROL 5 0.0018
6 TOFERSEN 1 0.0018
7 CLINDAMYCIN PHOSPHATE 7 0.0013
8 12%AZELAIC ACID 1 0.0012
9 SATRALIZUMAB 2 0.0011
See all drugs enriched for association with LUMBOSACRAL RADICULOPATHY

LUMBOSACRAL RADICULOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 alpha-Hydroxy Acid [EPC] 1 0.0005
2 Plasma Volume Expander [EPC] 1 0.0003
3 Sympathomimetic-like Agent [EPC] 9 0.0003
4 Cephalosporin Antibacterial [EPC] 2 0.0002
5 Neonatal Fc Receptor Blocker [EPC] 1 0.0002
6 Osmotic Diuretic [EPC] 1 0.0002
7 Allylamine Antifungal [EPC] 1 0.0001
8 Muscle Relaxant [EPC] 6 0.0001
9 Cannabinoid [EPC] 1 0.0001
See all drug classes enriched for association with LUMBOSACRAL RADICULOPATHY